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associated with atrial ﬁbrillation (AF) initiation and reentrant
mechanisms.
OBJECTIVE The purpose of this study was to assess the relationship
between bipolar voltage, CV dynamics, and AF drivers.
METHODS Patients undergoing catheter ablation for persistent AF
(,24 months) were enrolled. Unipolar electrograms were recorded
with a 64-pole basket catheter during atrial pacing at 4 pacing in-
tervals (PIs) during sinus rhythm. CVs were measured between pole
pairs along the wavefront path and correlated with underlying bipo-
lar voltage. CV dynamics within low-voltage zones (LVZs ,0.5 mV)
were compared to those of non-LVZs (0.5 mV) and were correlated
to driver sites mapped using CARTOFINDER (Biosense Webster).
RESULTS Eighteen patients were included (age 62 6 10 years).
Mean CV at 600 ms was 1.59 6 0.13 m/s in non-LVZs vs 0.98 6
0.23 m/s in LVZs (P ,.001). CV decreased incrementally over all 4
PIs in LVZs, whereas in non-LVZs a substantial decrease in CV was
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This is an open access article under the CCBY license (http://creativecommons.org/liRate-dependent CV slowing sites measurements, deﬁned as exhibit-
ing CV reduction 20% more than the mean CV reduction seen
between PIs 600–250 ms for that voltage zone, were predominantly
in LVZs (0.2–0.5 mV; 75.6% 6 15.5%; P ,.001). Conﬁrmed
rotational drivers were mapped to these sites in 94.1% of cases
(sensitivity 94.1%, 95% CI 71.3%–99.9%; speciﬁcity 77.9%, 95%
CI 74.9%–80.7%).
CONCLUSION CV dynamics are determined largely by the extent of
remodeling. Rate-dependent CV slowing sites are predominantly
conﬁned to LVZs (0.2–0.5 mV), and the resultant CV heterogeneity
may promote driver formation in AF.
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(Heart Rhythm 2019;16:18–25) Crown Copyright © 2018 Published
by Elsevier Inc. on behalf of Heart Rhythm Society. This is an open
access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).Introduction
The effect of structural remodeling on human left atrial (LA)
conduction velocity (CV) has been studied previously.1 Low-
voltage zones (LVZs) deﬁned by bipolar voltage1 and late
gadolinium enhancement on cardiac magnetic resonance
imaging2 have demonstrated lower local CVs, which may
promote reentry. This forms the rationale for current strate-
gies ablating LVZs for atrial ﬁbrillation (AF).2,3A direct relationship between bipolar voltage and CV in
the human LA has not been established. Therefore, how
CV changes over the spectrum of structural remodeling
seen in AF is unclear. CV dynamic curves in myocardial
tissue demonstrate a steep CV reduction with a decrease in
pacing interval (PI).4 In the presence of structural remodel-
ing, these curves are shifted to the right, whereby the
rate-adapted CV slowing occurs at longer PIs.5 These differ-
ences in CV dynamics have been shown to contribute to
reentry.4 Sites with marked slowing of CV with increasing
rate (ie, rate-dependent CV slowing) have been shown to
be associated with the ability to induce AF5 and correspond
to sites of reentry initiation at AF onset.6
We aimed to determine the interaction between remodel-
ing and CV dynamics by analyzing LVZs and local CVs in
the human LA using a 64-pole basket catheter. CV dynamics
were compared across a range of voltages, and the presence
of rate-dependent CV slowing was evaluated. Thehythm Society.
censes/by/4.0/).
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Diamond Bar, CA) was used to map AF7 to assess whether
abnormalities in CV dynamics are directly linked to the
mechanisms sustaining AF.Method
Study design
Patients undergoing catheter ablation for persistent AF (,24
months and no previous ablation) and in sinus rhythm at the
start of the case (before direct current cardioversion) were
included. Patients provided informed consent, and the study
was approved by the UK Research Ethics Committee (Lon-
don-Bloomsbury Research Ethics Committee, 16/LO/1379).
Electrophysiological mapping
Mapping was performed using the CARTOFINDER system
(see Supplemental Methods).7
LA geometry and high-density bipolar voltage map were
created using a PentaRay NAV catheter with 2-6-2 mm elec-
trode spacing (Biosense Webster) (see Supplemental
Methods). Voltage zones were deﬁned as non-LVZ
(0.5 mV), LVZ (0.2–0.5 mV), and very LVZ (vLVZ) (0–
0.2 mV).8 Unipolar electrograms were obtained using a Lab-
System Pro electrophysiological recording system (Bard
Electrophysiology Division, Natick, MA) by referencing to
a decapolar catheter (Biosense Webster) positioned in the
inferior vena cava. Filter bandwidth was 0.05–500 Hz.
A 64-pole basket catheter (Constellation, Boston Scienti-
ﬁc Ltd, Natick, MA; or FIRMap, Abbott, Santa Clara, CA)
was used to record unipolar signals. It was positioned in
the LA to achieve the best possible atrial coverage.9
Pacing procedure
To achieve wavefront propagations in different directions,
atrial pacing was performed in sinus rhythm with the ablation
catheter from 4 sites: proximal and distal coronary sinus
(endocardial), LA roof, and LA appendage. Uninterrupted
pacing was performed at 4 PIs: 600, 450, 300, and 250 ms.
For each PI, 30-seconds of unipolar electrograms were
recorded at a sampling frequency of 2000 Hz. A location
point was also taken on CARTO to obtain 3-dimensional
coordinates for each pole.
Local CVs
CV was deﬁned as the geodesic distance divided by the
activation time difference and expressed in m/s (see
Supplemental Methods).10
CV dynamics and bipolar voltage
Using a MATLAB custom-written script (The MathWorks,
Natick, MA), the position of the electrode pairs included in
the analysis and bipolar voltage points taken with the Pen-
taRay catheter were projected onto the LA geometry. The
bipolar voltage points were considered within a 5-mm band
between the electrodes from which CV was assessed. The
mean of these was taken as the local bipolar voltage alongthe path between each electrode pair and used to deﬁne the
voltage zone along the path.
When the distance between electrodes for measurement of
CV was seen to traverse different voltage zones, then mea-
surements were excluded so as to avoid CV measurements
over heterogenous tissues. CV at each PI was compared in
the 3 voltage zones. To evaluate for heterogeneity in CV
dynamics within LVZs and non-LVZs, sites of rate-
dependent CV slowing were identiﬁed. These were deﬁned
as zones exhibiting a reduction in CV between PI 5 600
ms and PI5 250 ms of20%more than the mean CV reduc-
tion seen between these PIs for that voltage zone.
CV and AF driver sites
AFwas induced after the study protocol by burst atrial pacing
from the coronary sinus (see Supplemental Methods).
CARTOFINDERmaps were then created before and after
pulmonary vein isolation (PVI), and the maps post-PVI were
used to guide further ablation. A potential driver was deﬁned
as either (1) focal with radial activation over 2 consecutive
wavefronts or (2) rotational activity with 1.5 rotations of
360.7 Conﬁrmed drivers were deﬁned as sites at which abla-
tion terminated AF into atrial tachycardia (AT) or sinus
rhythm or slowed AF cycle length by 30 ms.7
Ablation strategy
The ablation strategy used in this study has previously been
deﬁned (see Supplemental Methods).7
Statistical analysis
Statistical analysis was performed using SPSS Statistics
Version 24 (IBM Corp, Armonk, NY). Continuous variables
are given as mean 6 SD. Categorical variables are given as
number (percentage). The c2 test was used for comparison
of nominal variables. The Student t-test or its nonparametric
equivalent, the Mann-Whitney U test, was used when appro-
priate for comparison of continuous variables. Spearman
rank order correlation was used to assess the strength and
association between CV and bipolar voltage. The paired Stu-
dent t test was used to compare CVs obtained for each PI.
One-way analysis of variance was used to compare CV
changes over the PIs between voltage zones. Receiver oper-
ating characteristic curves were obtained to determine the
diagnostic ability of different parameters in predicting driver
sites. P ,.05 was considered signiﬁcant.Results
Eighteen patients were included in the study (Supplemental
Table 1).
Bipolar voltage and CV
A total of 15,363 bipolar voltage points were taken with an
average of 854 6 240 points per patient, of which 487 6
188 points were ,0.5 mV (57% 6 22%). Mean bipolar
voltage was 0.43 6 0.18 mV. LVZs were found to occur as
islands or plaques, each one covering a minimum of 10%
Figure 1 Anterior (A) and posterior (B) views of the left atrium showing the distribution of the low-voltage zones and rate-dependent conduction velocity
slowing sites (percentage in brackets) in the patients involved in the study. Red indicates septum; green indicates lateral; blue indicates anterior; yellow indicates
posterior; purple indicates roof.
20 Heart Rhythm, Vol 16, No 1, January 2019of the LA surface (29% 6 15%). LVZs predominantly
affected the anterior wall (33%) (Figure 1).
CV was determined over a total of 3197 electrode pairs,
with a mean of 45.86 8.2 pairs for each activation sequence
in each patient. At PI 5 600 ms, mean CV was higher in
non-LVZs than LVZs (Figure 2A). There was a positive
correlation between the mean CV for a patient and both
mean bipolar voltage (rs 5 0.95; P ,.001) (Figure 3A) and
proportion of non-LVZs (rs 5 0.87; P ,.001) (Figure 3B).Figure 2 A: Change in CV over the 4 pacing intervals in non-LVZs0.5 mV (bl
(dark gray triangles). B, C: Bar chart showing the percentage of rate-dependent CV
mV) (B) and the proportion of non-LVZs0.5 mV, LVZs (0.2–0.5mV), and LVZs
velocity; LVZ 5 low-voltage zone; RD-CV 5 rate-dependent conduction velocityCV dynamics and bipolar voltage
As shown in Figure 2A and Supplemental Table 2, CV dy-
namics signiﬁcantly differed at sites of non-LVZs, LVZs
(0.2–0.5 mV) and vLVZs (0–0.2 mV). In non-LVZs, CVs
only signiﬁcantly changed between PIs of 300–250 ms
(0.59 6 0.09 m/s; P ,.001), with a total average reduction
of 62.9% 6 6.9% between PIs 600–250 ms, whereas the
activation time increased by an average of 12 6 5 ms. In
LVZs (0.2–0.5 mV), there was a progressive decrease inack triangles), LVZs (0.2–0.5 mV) (light gray circles), and LVZs (0–0.2 mV)
slowing sites in non-LVZs0.5 mV, LVZs (0.2–0.5 mV), and LVZs (0–0.2
(0–0.2 mV) demonstrating rate-dependent CV slowing (C). CV5 conduction
.
Figure 3 Relationship betweenmean CV for each patient at pacing interval of 600ms (the average of all the CVmeasured between all pole pairs in each patient)
and mean bipolar voltage including all bipolar voltage points in each patient (A) and the proportion of non-LVZs in each patient (B). CV5 conduction velocity;
LVZ 5 low-voltage zone.
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23.7% 6 13.6% between PIs 600–250 ms. The activation
time increased by an average of 9 6 3 ms. In vLVZs (0–
0.2 mV), there was minimal change in CV with increased
pacing rate (mean change 0.02 6 0.02 m/s over each PI;
P 5.48).Table 1 Mechanism of possible drivers mapped in AF and ablation
response
AF drivers 29
Focal activity 11
Rotational activity 18
AF response to ablation at driver site 29
Termination to sinus rhythm 6
Organized to an AT 12
Cavotricuspid isthmus-dependent ﬂutter 2
Mitral isthmus-dependent ﬂutter 4
Roof-dependent ﬂutter 5
Ligament of Marshall 1
Cycle length slowing 30 ms 7
No effect of ablation 4
Values are given as n.
AF 5 atrial ﬁbrillation; AT 5 atrial tachycardia.Relationship between rate-dependent CV slowing
sites and bipolar voltage
For each pacing site, a mean of 10.7 6 4.3 rate-dependent
CV slowing measurements were observed per patient
(24.0% 6 11.9% of sites sampled), with a mean 1.46 6
0.64 rate-dependent CV slowing sites per patient (total
of 41 rate-dependent CV slowing sites in the 18 patients),
which were spatially stable. Rate-dependent CV slowing
site measurements were signiﬁcantly more common in
LVZs than non-LVZs (75.6% 6 15.5% vs 24.4% 6
15.0; P ,.001) (Figure 2B). In all, 14.0% 6 4.3% of
LVZs exhibited rate-dependent CV slowing compared to
7.8% 6 4.8% of non-LVZs (P ,.001). Rate-dependent
CV slowing sites were more prevalent in patients with a
lower mean bipolar voltage (rs 5 –0.91; P ,.001). Rate-
dependent CV slowing sites were more commonly mapped
to the anterior (37%) and posterior (24%) wall, which
correlated to sites where LVZs were more frequent
(Figure 1).
Rate-dependent CV slowing sites in LVZs were all LVZs
(0.2–0.5 mV) and showed progressive decrease in CV over
all 4 PIs (mean decrease in CV of 0.12 6 0.03 m/s for each
PI), resulting in broader curves. Rate-dependent CV slowing
sites in non-LVZs showed the greatest decrease in CV be-
tween PIs of 300–250 ms (mean decrease in CV of 0.70 6
0.09 m/s; P 5 .001), with minimal change at longer PIs,
resulting in a steeper curve.Relationship between LVZs and rate-dependent CV
slowing and drivers
In the 18 AF patients, 29 possible drivers were identiﬁed
using the CARTOFINDER system (1.66 0.7 drivers per pa-
tient; n 5 18 rotational activity and n 5 11 focal activity).
Ablation at 25 of the 29 driver sites (n 5 8 focal and
n 5 17 rotational; 86.2%) resulted in an effect that met the
study criteria of a conﬁrmed driver (Table 1). With 4 drivers,
the predeﬁned ablation response was not seen on ablation
(n 5 3 focal and n 5 1 rotational).
The drivers demonstrated spatial stability but temporal
periodicity, with a consecutive repetition of 3.8 6 1.1 and
a recurrence rate of 8.26 4.8 times per 30-second recording.
Eighteen of the 25 conﬁrmed AF drivers were mapped to
LVZs (72.0%), which included 15 of the 17 conﬁrmed
drivers with rotational activation (88.2%) but only 3 of 8
conﬁrmed drivers with focal activation (37.5%; P 5 .02).
Mean bipolar voltage was 0.33 6 0.10 mV at the conﬁrmed
driver sites. No drivers were identiﬁed in vLVZs.
Figure 4 A: i–iv: Still CARTOFINDER map demonstrating a rotational driver at the anterior roof (B) in an area of LVZ as shown on the bipolar voltage map
(C), where ablation resulted in atrial ﬁbrillation termination to sinus rhythm on the Bard electrograms. D: i: Replicated CARTO geometry created in MATLAB
demonstrating site of rate-dependent conduction velocity (CV) slowing at the anterior roof in an area of LVZ (0.2–0.5 mV) (F3–F5 electrodes; vertical and F4–E4
electrode: horizontal). ii: Electrograms obtained at F3 and F5 electrodes during left atrial appendage pacing at PI 600–250 ms show an increase in activation time
difference of 12 ms (80% increase) between the 2 electrodes when reaching PI of 250 ms. (iii) Electrograms obtained at F4 and E4 electrodes during roof pacing at
PI 600–250 ms show an increase in activation time difference of 13 ms (163% increase). LVZ5 low-voltage zone; PI5 pacing interval; V5 far-ﬁeld ventricular
signal.
22 Heart Rhythm, Vol 16, No 1, January 2019Eighteen of the 25 conﬁrmed drivers (72.0%) were found
at rate-dependent CV slowing sites (Supplemental Figure 1
and Supplemental Table 3), which included 16 of the 17
conﬁrmed drivers with rotational activation (94.1%) but
only 2 of 8 (25.0%) with focal activation (P5 .001). Notably,
15 of the 18 (83.3%) conﬁrmed drivers that resulted in AF
termination were mapped to rate-dependent CV slowing sites
(Figure 4).Potential predictive factors of conﬁrmed driver
sites
LVZs predicted driver sites with sensitivity of 72.0% (95%
conﬁdence interval [CI] 50.4%–87.1%) and speciﬁcity of
43.4% (95% CI 40.0%–46.9%).
Rate-dependent CV slowing sites showed sensitivity and
speciﬁcity of 72.0% (95% CI 50.6%–87.9%) and 78.1%
(95% CI 75.0%–80.9%), respectively, for predictingTable 2 Value of different factors in predicting drivers in AF
Each LVZ island AUC P value
Surface area (cm2) 0.63 .13
Mean bipolar voltage (mV) 0.81 ,.001
SD of mean bipolar voltage (mV) 0.46 .62
CV at 600 ms (m/s) 0.76 .002
% CV measurements demonstrating rate-dependent
CV slowing
0.86 ,.001
AF 5 atrial ﬁbrillation; AUC 5 area under the curve; CI 5 conﬁdence interval;conﬁrmed driver sites in AF, and sensitivity and speciﬁcity
of 94.1% (95% CI 71.3%–99.9%) and 77.9% (95% CI
74.9%–80.7%), respectively, for predicting drivers with rota-
tional activity. When only the 18 conﬁrmed drivers mapped
to LVZs were included, rate-dependent CV slowing sites
showed sensitivity and speciﬁcity of 83.3% (95% CI
57.7%–95.6%) and 83.7% (95% CI 81.0%–86.2%), respec-
tively, for predicting AF driver sites. Table 2 shows the value
of different factors in predicting AF drivers mapped to LVZs.Discussion
This is the ﬁrst study to assess the interaction between CV dy-
namics and bipolar voltage in the human LA. A direct corre-
lation between CV and bipolar voltage was observed.
However, CV dynamics were not determined entirely by
the presence or absence of LVZs, and not all LVZswere asso-
ciated with rate-dependent CV slowing. Although CV was95% CI
Optimal cutoff
value Sensitivity Speciﬁcity
0.47–0.79 3.0 0.68 0.67
0.68–0.93 0.28 0.88 0.63
0.29–0.63 0.10 0.56 0.50
0.62–0.90 1.17 0.76 0.71
0.73–0.98 19.1 0.80 0.91
CV 5 conduction velocity; LVZ 5 low-voltage zone.
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rate-dependent CV slowing. Sites of rate-dependent CV
slowing predicted the sites of rotational activity in AF with
high sensitivity and speciﬁcity, supporting the hypothesis
that the rate-dependency of CV dynamics is mechanistically
important in the development of reentrant arrhythmias.CV and bipolar voltage
LVZ were clustered in relatively large regions rather than
scattered throughout the myocardium. The focal nature of
this remodeling process has been observed previously9 and
enabled accurate assessment of CV dynamics within these
zones. CV at 600 ms PI was reduced by about 15% in LVZ
(0.2–0.5 mV) and 40% in vLVZs (0–0.2 mV) compared to
non-LVZs0.5 mV, suggesting that CV slows progressively
with ﬁbrosis. The strong correlation between mean CV and
both mean bipolar voltage and proportion of non-LVZs
demonstrates a strong link between structural and electrical
remodeling.CV dynamics and bipolar voltage
CV dynamics curves alter with structural remodeling,4 which
was consistent with the study ﬁndings. With structural re-
modeling there is replacement of myocardial tissue by
ﬁbrosis,6 alteration in gap junction communication,11 and
coupling of myocytes with ﬁbroblasts.12 These phenomena
may contribute to the slowing of conduction and altered
CV dynamics seen in LVZs.
Atrial CV dynamics curves have not previously been stud-
ied in relation to structural remodeling. Patients with persis-
tent AF have been shown to have broader CV dynamics
curves than those with paroxysmal AF.5,13 The ﬁnding that
areas of structural remodeling have broad CV dynamics
curves may explain this ﬁnding because atria in patients
with persistent AF are often more dilated and scarred than
in those with paroxysmal AF.14Relationship between rate-dependent CV slowing
and drivers
Rate-dependent CV slowing sites were predominantly
located in LVZs, and their prevalence increased with the pro-
portion of the atrium made up by LVZs. Interestingly, they
were limited to LVZs (0.2–0.5 mV). This is probably because
this tissue is healthy enough to be capable of near-normal CV
at longer PIs (600 ms) but is abnormal enough to reduce CV
signiﬁcantly with shorter PIs (,600 ms). In vLVZs (0–
0.2 mV), tissue is likely to be markedly diseased, as reﬂected
by the already very slow CV at 600 ms PI. This then shows
little further slowing in CV at shorter PIs (ie, there is no
conduction reserve).
Rate-dependent CV slowing sites were also seen in non-
LVZs. Why certain areas with no ﬁbrosis/scar showed
enhanced CV slowing with rate is unclear. It is possible
that sites deﬁned as non-LVZs are not truly structurally
normal, and there is the presence of subendocardial or epicar-
dial ﬁbrosis that would not be identiﬁed on endocardialbipolar voltage maps. This could account for the heterogene-
ity seen in apparently healthy tissue. However, these sites did
not correlate to the location of reentry causing rotational
activity in AF and therefore may not play an important mech-
anistic role. It may be that structural remodeling must be
transmural to effectively promote reentry.
In this study, the majority of drivers had a rotational
activation (62.0%), which is supported by the ﬁndings of
our previous work.7 It has been suggested that localized
slow conduction is necessary to maintain rotors, or at least
that rotors may become anchored to such areas.15 In this
study, 15 of the 17 conﬁrmed drivers with rotational activa-
tion pattern were located in LVZs (0.2–0.5 mV) with
rate-dependent CV slowing. The 11 focal activation patterns
showed no predilection to LVZs and rate-dependent CV
slowing sites, which is consistent with previous ﬁndings.16
It has been shown that sites with a broad CV dynamics curve
have an alteration in activation vector and arcing with accel-
erated rates, which may reﬂect rate-dependent conduction
block in certain directions.5 This may promote reentry.17
These data suggest that sites with a broad CV dynamics curve
and enhanced rate-dependent CV slowing play an important
role in the initiation and/or maintenance of reentrant mecha-
nisms supporting AF. It may also explain why ablation of
such areas has an organizing effect without simply creating
an area of ﬁxed conduction block to which reentry might
anchor. It may be that ablation reduces the heterogeneity of
CV by eliminating areas of rate-dependent CV slowing
without the need to necessarily produce areas of continuous
conduction block.
To our knowledge, CV restitution in the human atrium and
its relationship to drivers mapped in AF have not previously
been assessed. However, animal studies and computer
modeling data investigating ventricular ﬁbrillation have
shown that rotors are associated with a broad CV restitution
curve.18 This is consistent with the study ﬁndings whereby
rotational drivers mapped to areas with a broad restitution
curve and rate-dependent CV slowing.
The prevalence of rate-dependent CV slowing sites in
LVZs may explain the poorer short- and long-term outcomes
of AF catheter ablation in patients with more diseased atria.19
The study ﬁndings do point toward a potential role for a sub-
strate modiﬁcation approach to AF ablation based on LVZs
and CV dynamics, because sites of rate-dependent CV slow-
ing correlate to AF driver sites. Substrate modiﬁcation based
on voltage has shown promising results.2,3 These data
suggest that the targeting of scar could potentially be
reﬁned based on electrophysiological criteria.
Animal studies have elegantly shown that rotors can be
functional and occur in normal tissue. We have previously
demonstrated that drivers with rotational activity show a
predilection for LVZs and that the amount of LVZ is predic-
tive of the identiﬁcation of rotational drivers.20 Others have
demonstrated this independently using separate technolo-
gies.21 Computer modeling has suggested that ﬁbrosis can
anchor a rotor.22 It has also been shown that CV heterogene-
ity can promote reentry.4 Therefore, it is possible that rotors
24 Heart Rhythm, Vol 16, No 1, January 2019and other reentrant mechanisms might form within or gravi-
tate toward LVZs, particularly those with heterogeneous
conduction due to rate-dependent CV slowing.Study limitations
One of the main limitations of this study is the small patient
numbers. This was overcome to some extent by assessing
CV between more than a total of 3000 electrode pairs to
allow regional analysis of multiple LVZs. The LA coverage
achieved with the basket catheter is limited by catheter
design and LA geometry, so the number of rate-dependent
CV slowing sites may be underestimated. In this study,
wavefront collision was not seen between electrode pairs
over which CV was measured, but clearly this would impact
CV measurements. Studies evaluating CV should consider
this as a potential source of error and adjust the pacing
site if needed.
The impact of ﬁber orientation and anisotropic effect on
CV was not directly assessed in this study. However, sites
of rate-dependent CV slowing were spatially stable and
were not impacted by pacing site or the direction of wave-
front propagation and thus are unlikely to be explained by
anisotropy.
The aim of the study was to map the LA for possible AF
drivers and assess for CV heterogeneity. Right atrial (RA)
mapping with the CARTOFINDER system has not demon-
strated RA drivers,7 so the RA was not mapped in this study.
Therefore, whether this relationship between CV dynamics
and drivers exists in the RA is uncertain.
What recording duration is optimal for the identiﬁcation of
potential drivers in AF remains unclear. It is possible that a
longer recording may have identiﬁed more drivers. The
CARTOFINDER mapping system uses a 30-second
recording similar to that used by other mapping systems.23,24
However, the drivers identiﬁed were observed repeatedly,
and the response to ablation suggested they were
mechanistically important. Indeed, drivers that demonstrate
greater temporal stability may be more important in
maintaining AF.20 The relevance of focal or rotational activ-
ity that occurs less frequently remains unclear.
In this study, we focused on electrophysiological end-
points to determine the mechanistic signiﬁcance of potential
drivers because there is arguably no other way to verify that a
driver has been mapped. Other investigators have used termi-
nation of AF or cycle length prolongation as a surrogate for
the interruption of mechanisms important for the mainte-
nance of AF.25,26 Larger multicenter studies powered to
assess outcomes are currently in progress using
CARTOFINDER to target drivers in AF (Clinicaltrials.gov
Identiﬁer: NCT03064451).
The voltage ranges studied were those conventionally re-
garded as LVZ, but it is accepted that areas with voltage.0.5
mV could still be abnormal. Further studies to deﬁne the
lower limits of the normal range are desirable.
The current study used the ablation response to conﬁrm
the presence of drivers so as to correlate this with sites ofCV heterogeneity. Further studies are needed to determine
the impact of an approach targeting ablation based on local
CV dynamics.Conclusion
Structural remodeling results in heterogeneous CV dy-
namics, which are determined largely by the degree of atrial
disease. Moderately diseased tissue (0.2–0.5 mV) was most
likely to display rate-dependent CV slowing, which showed
a good correlation with rotational activation in AF. Notably,
not all areas with voltage ,0.5 mV seemed mechanistically
important in this way. These data provide a potential rationale
for randomized studies comparing long-term outcomes of an
electrophysiological approach to substrate modiﬁcation for
AF based on CV dynamics to other ablation strategies.Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at https://doi.org/10.1016/j.hrthm.2018.
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